Summary
Numbers of biochemical abnormalities which may be relevant to the degenerative process of nigral dopaminergic neurons have been described. These include accumulation of iron in substantia nigra, decrease in the enzymatic activity and the amount of subunits of mitochondrial complex I, increase in the amount of deleted mitochondrial DNA, and possible increase in oxygen derived free radicals. Recent progress in this field is reviewed in this communication. Although the primary cause of Parkinson’s disease is still unknown, these abnormalities listed above will contribute to the progression of the degenerative process. In addition, we report our recent data on the toxic effects of iron and synthetic dopamine melanin on cultured dopaminergic neurons, and discuss possible interaction of iron and mitochondrial DNA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albores R, Heafsey EJ, Drucker G, Fields JZ, Collins MA (1990) Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine. Proc Natl Acad Sci USA 87: 9368–9372
Ambani LM, Van Woert H, Murphy S (1975) Brain peroxidase and catalase in Parkinson disease. Arch Neurol 32: 114–118
Anderson S, Bankier AT, Barrell BG, de Bruijn MHL, Coalson AR, Drouin J, Eperon IC, Nierlich DD, Roe BA, Sanger F, Schreier PH, Smith AJH, Staden R, Young IG (1981) Sequence and organization of the human mitochondrial genome. Nature 90: 457–465
Anderson S, de Bruijn MHL, Coulson AR, Eperon IC, Sanger F, Young IG (1982) Complete sequence of bovine mitochondrial DNA: conserved features of the mammalian mitochondrial genome. J Mol Biol 156: 683–717
Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR (1992) Mutant debrisoquine hydroxylation genes in Parkinson’s disease. Lancet 339: 10171018
Bindoff LA, Birch-Machin M, Cartlidge NEF, Parker WD Jr, Turnbull DM (1989) Mitochondrial function in Parkinson’s disease. Lancet 11: 49
Ben-Shachar D, Riederer P, Youdim MBH (1991) Iron-melanin interaction and lipid peroxidation: implications for Parkinson’s disease. J Neurochem 57: 1609–1614
Capaldi RA (1982) Arrangement of proteins in the mitochondrial inner membrane. Biochem Biophys Acta 694: 291–306
Caron F, Jacq C, Rouviere-Yaniv (1979) Characterization of a histon-like protein extracted from mitochondria. Proc Natl Acad Sci USA 76: 4265–4269
Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, cause G–T and A —003E C substitutions. J Biol Chem 267: 166–172
Chomyn A, Mariottini P, Cleeter MWJ, Ragan CI, Matsuno-Yagi A, Hatefi Y, Doolittle RF, Attardi G (1985) Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenase. Nature 314: 592–597
Chomyn A, Cleeter MWJ, Ragan CI, Riley M, Dolittle RF, Attardi G (1986) URF6, last unidentified reading frame of human mtDNA codes for an NADH dehydrogenase subunit. Science 234: 614–618
Clayton DA (1982) Replication of animal mitochondrial DNA. Cell 28: 693–705
Collins MA, Neafsey EJ, Matsubara K, Cobuzzi RJ Jr, Rollema H (1992) IndolN-methylated 13-carbolinium ions as potential brain-bioactivated neurotoxins. Brain Res 570: 154–160
Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC (1992) Mitochondria) DNA deletions in human brain; regional variability and increase with advanced age. Nature Genet 2: 324–329
Cortopassi GA, Arnheim N (1990) Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucl Acids Res 18: 6927–6933
Das KC, Abramson MB, Katzman R (1976) Neural pigments: spectroscopic characterization of human brain melanin. J Neurochem 40: 601–605
Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989a) Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J Neurochem 52: 381–389
Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989b) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson’s disease. J Neurochem 52: 1830–1836
Drucker G, Raikoff K, Neafsey EJ, Collins MA (1990) Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP) oxidation products. Brain Res 509: 125–133
Gibb WRG, Lees AJ (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson’s disease. J Neurol Neurosurg Psychiatry 54: 388–396
Good PF, Olanow CW, Perl DP (1992) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson’s disease: a LAMMA study. Brain Res 593: 343–346
Gross NJ, Getz GS, Rubinowitz M (1969) Apparent turnover of mitochondrial deoxyribonucleic acid and mitochondrial phospholipids in the tissue of rat. J Biol Chem 244: 1552–1562
Halliwell B (1989) Oxidants and the central nervous system: some fundamental questions. Acta Neurol Scand 126: 23–33
Hatefi Y (1985) The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54: 1015–1069
Hattori K, Tanaka M, Sugiyama S, Obayashi T, Ito T, Satake T, Hanaki Y, Asai J, Nagano M, Ozawa T (1991) Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am Heart J 121: 1735–1742
Hattori N, Tanaka M, Ozawa T, Mizuno Y (1991) Immunohistochemical studies on Complex I, II, III, and IV of mitochondria in Parkinson’s disease. Ann Neurol 30: 563–571
Hayakawa M, Ogawa T, Sugiyama S, Tanaka M, Ozawa T (1991 a) Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine. Biochem Biophys Res Commun 176: 87–93
Hayakawa M, Toni K, Sugiyama S, Tanaka M, Ozawa T (1991b) Age-associated accumulation of 8-hydroxydeoxyguanosine in mitochondrial DNA of human diaphragm. Biochem Biophys Res Commun 179: 1023–1029
Heikkila RE, Nicklas WL, Vyas I, Duvoisin RC (1985) Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl1,2,5,6-tetrahydropyridine toxicity. Neurosci Lett 62: 389–394
Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson’s disease: an X-ray microanalysis. J Neurochem 56: 446–451
Ikebe S, Tanaka M, Ohno K, Sato W, Hattori K, Kondo T, Mizuno Y, Ozawa T (1990) Increase of deleted mitochondrial DNA in the striatum in Parkinson’s disease and senescence. Biochem Biophys Res Commun 170: 1044–1048
Jellinger K, Paulus W, Grundke-Iqbal P, Riederer P, Youdim MBH (1990) Brain iron and ferritin in Parkinson’s and Alzheimer’s disease. J Neural Transm [P-D Sect] 2: 327–340
Jellinger K, Kienzl E, Rumpelmair G, Riederer P, Stachelberger H, Ben-Shachar D, Youdim MBH (1992) Iron-melanin complex in substantia nigra parkinsonian brains: an X-ray microanalysis. J Neurochem 59: 1168–1171
Johannsen P, Velander G, Mai J, Thorling EB, Dupont E (1991) Glutathione peroxidase in early and advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 54: 679–682
Kagawa Y, Sone N (1979) DCCD-sensitive ATPase (TF0 • Fi) from a thermophilic bacterium: purification, dissociation into functional subunits, and reconstitution into vesicles capable of energy transformation. In: Fleischer S, Packer L (eds) Methods in enzymology, vol LV. Academic Press, New York, pp 364–372
Kish SJ, Morito C, Hornykiewicz 0 (1985) Glutathione peroxidase activity in Parkinson’s disease. Neurosci Lett 58: 343–346
Koga S, Nakano M (1992) A high involvement of 02-possibly generated in inner membranes for iron-induced microsomal lipid peroxidation. Biochem Biophys Res Commun 186: 1087–1093
Kondo K, Watanabe K (1993) Lifestyles, risk factors, and inherited predispositions in Parkinson’s disease: preliminary report of a case-control study. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds) Advances in neurology, vol 60. Raven Press, New York, pp 346–351
Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AHV (1992) Platelet mitochondrial function in Parkinson’s disease. Ann Neurol 32: 782–788
Kunkel TA, Loeb LA (1981) Fidelity of mammalian DNA polymerase. Science 213: 765–767
Lestienne P, Nelson J, Riederer P, Jellinger K, Reichmann H (1990) Normal mitochondrial genome in brain from patients with Parkinson’s disease and complex I defect. J Neurochem 55: 1810–1812
Linnane AW, Marzuki S, Ozawa T, Tanaka M (1989) Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet is 642–645
Linnane AW, Baumer A, Maxwell RJ, Preston H, Zhang C, Marzuki S (1990) Mitochondrial gene mutation: the ageing process and degenerative diseases. Biochem Int 22: 1067–1076
Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD (1992) Brain skeletal muscle and platelet homogenate mitochondrial function in Parkinson’s disease. Brain 115: 333–342
Marttila RJ, Lorentz H, Rinne UK (1988) Oxygen toxicity protecting enzymes in Parkinson’s disease: increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 86: 321–331
Merle P, Kadenbach B (1980) The subunit composition of mammalian cytochrome c oxidase. Eur J Biochem 105: 499–507
Minakami H, Arai H, Nakano M, Sugioka K, Suzuki S, Sotomatsu A (1988) A new and suitable reconstructed system for NADPH-dependent microsomal lipid peroxidation. Biochem Biophys Res Commun 153: 973–978
Mizuno Y, Sone N, Saitoh T (1986) Dopaminergic neurotoxin, MPTP and MPP`, inhibit mitochondrial NADH-ubiquinone oxidoreductase activity. Proc Jpn Acad Ser B 62: 261–263
Mizuno Y, Sone N, Saitoh T (1987) Effects of 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of enzymes in the electron transport system in mouse brain. J Neurochem 48: 1787–1793
Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson’s disease. Biochem Biophys Res Commun 163: 1450–1455
Mizuno Y, Suzuki K, Ohta S (1990) Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson’s disease. J Neurol Sci 96: 49–57
Mochizuki H, Nishi K, Mizuno Y (1993) Iron-melanin complex is toxic to dopaminergic neurons in a nigrostriatal co-culture. Neurodegeneration 2: 1–7
Nagatsu T, Yoshida M (1988) An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterine in the nigrostriatal regions. Neurosci Lett 87: 178–182
Nakagawa-Hattori Y, Yoshino H, Kondo T, Mizuno Y, Horai S (1992) Is Parkinson’s disease a mitochondrial disorder? J Neurol Sci 107: 29–33
Naoi M, Matsuura S, Takahashi T, Nagatsu T (1989a) A N-methyltransferase in human brain catalyzes N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahyroisoquinoline, a precursor of a dopaminergic neuro-toxin N-methylisoquinolinium ion. Biochem Biophys Res Commun 161: 1213–1219
Naoi M, Matsuura S, Parvez H, Takahashi T, Hirata Y, Minami M, Nagatsu T (1989b) Oxidation of N-methyl- 1,2,3,4-tetrahydroisoquinoline into the Nmethyl-isoquinolinium ion by monoamine oxidase. J Neurochem 52: 653–655
Nicklas WL, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 36: 2503–2508
Nishi K, Akins PT, Surmier DJ, Kitai ST (1990) Muscarinic regulation of cyclic AMP metabolism in rat neostriatal cultures. Brain Res 543: 111–116
Niwa T, Takeda N, Kaneda N, Hashizume Y, Nagatsu T (1987) Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroisoquinoline in parkinsonian and normal human brains. Biochem Biophys Res Commun 144: 1084–1089
Ohta S, Kohno M, Makino Y, Tachikawa O, Hirobe M (1987) Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson’s disease. Biomed Res 8: 453–456
Ozawa T, Tanaka M, Ikebe S, Ohno K, Kondo T, Mizuno Y (1990) Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. Biochem Biophys Res Commun 172: 483–489
Parker WD Jr, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson’s disease. Ann Neurol 26: 719–723
Perry TL, Yong VW (1986) Idiopathic Parkinson’s disease, progressive supra-nuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 67: 269–274
Ragan CI (1987) Structure of NADH-ubiquinone reductase (Complex I). In: Lee CP (ed) Current topics in bioenergetics: structure, biogenesis, and assembly of energy transducing enzyme systems. Academic Press, San Diego, pp 1–36
Ragan CI, Galante YM, Hatefi Y (1982) Purification of three iron-sulfur proteins from the iron-protein fragment of mitochondrial NADH-ubiquinone oxidoreductase. Biochemistry 21: 2518–2514
Rajput AH, Uitti RJ, Stern W, Laverty K, O’Donnell K, O’Donnel D, Yuen WK, Dua A (1987) Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson’s disease. Can J Neurol Sci 14: 414–418
Ramsay RR, Salach JI, Dadgar J, Singer TP (1986) Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism. Biochem Biophys Res Commun 135: 269–275
Reichmann H, Riederer P, Seufert S (1990) Disturbances of the respiratory chain in brain from patients with Parkinson’s disease. Mov Disord 5: 28 (abstr)
Reichmann H, Lestienne P, Jellinger K, Riederer P (1993) Parkinson’s disease and the electron transport chain in postmortem brain. In: Narabayashi H, Nagastu T, Yanagisawa N, Mizuno Y (eds) Advances in neurology, vol 60. Raven Press, New York, pp 297–299
Richter C, Park J-W, Ames BN (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85: 6465–6467
Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515–520
Saggue H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD (1989) A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53: 692–697
Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson’s disease. Lancet is 1269
Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990a) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54: 823–827
Schapira AHV, Holt IJ, Sweeney M, Harding AE, Jenner P, Marsden CD (19906) Mitochondrial DNA analysis in Parkinson’s disease. Mov Disord 5: 294–297
Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC (1991) Mitochondrial oxidative phosphorylation defects in Parkinson’s disease. Ann Neurol 30: 332–339
Simonetti S, Chen X, DiMauro S, Schon EA (1992) Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochim Biophys Acta 1180: 113–122
Singer TP, Ramsay RR (1990) Mechanism of the neurotoxicity of MPTP. FEBS Lett 274: 1–8
Smith CA, Gough AC, Leigh PN, Summers BA, Harding AE, Maranganore DM, Sturman SG, Schapira AV, Williams AC, Spurr NK, Wolf CR (1992) Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson’s disease. Lancet 339: 1375–1377
Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MBH (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56: 978–982
Soong NW, Hinton DR, Cortopassi G, Amheim N (1992) Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genet 2: 318–323
Suzuki K, Mizuno Y, Yamauchi Y, Nagatsu T, Yoshida M (1992) Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain. J Neurol Sci 109: 219–223
Tanaka M, Sato W, Ohno K, Yamamoto T, Ozawa T (1989) Direct sequencing of deleted mitochondrial DNA in myopathie patients. Biochem Biophys Res Commun 184: 156–163
Tanner CM, Chen B, Wang W, Peng M, Liu Z, Liang X, Kao LC, Gilley DW, Goeta CG, Schoenberg BS (1989) Environmental factors and Parkinson’s disease: a case-control study in China. Neurology 39: 660–664
Tasaki Y, Makino Y, Ohta S, Hirobe M (1991) 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-terahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. J Neurochem 57: 1940–1943
Walker JE (1992) The NADH: ubiquinone oxidoreductase of respiratory chains. Quart Rev Biophys 25: 253–324
Walker JE, Arimendi JM, Dupuis A, Fearnley IM, Finel M, Medd SM, Pilkington SJ, Runswick MJ, Skehel JM (1992) Sequences of 20 subunits of NADH: ubiquinone oxidoreductase from bovine heart mitochondria: application of anovel strategy for sequencing proteins using the polymerase chain reaction. J Mol Biol 226: 1051–1072
Weiss H, Friedrich T (1991) Redox linked proton translocation by NADH- ubiquinone reductase (complex I). J Bioenerget Biomembr 23: 743–754
Yen T-C, Su J-H, King K-L, Wei Y-H (1991) Ageing-associated 5 kb deletion in human liver mitochondria) DNA. Biochem Biophys Res Commun 178: 124–131
Yoshida M, Niwa T, Nagatsu T (1990) Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes. Neurosci Lett 119: 109–113
Yoshino H, Nakagawa-Hattori Y, Kondo T, Mizuno Y (1992) Mitochondrial complex I and complex II activities of lymphocytes and platelets in Parkinson’s disease. J Neural Transm [P-D Sect] 4: 27–34
Youdim MBH, Ben-Shachar D, Riederer P (1989) Is Parkinson’s disease a progressive siderosis of substantia nigra resulting in ion and melanin induced neurodegeneration? Acta Neurol Scand 126: 47–54
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag/Wien
About this paper
Cite this paper
Mizuno, Y., Mochizuki, H., Nishi, K., Ikebe, Si., Hattori, N., Hattori-Nakagawa, Y. (1993). Pathogenesis of Parkinson’s disease: iron and mitochondrial DNA deletion. In: Riederer, P., Youdim, M.B.H. (eds) Iron in Central Nervous System Disorders. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9322-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9322-8_10
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82520-4
Online ISBN: 978-3-7091-9322-8
eBook Packages: Springer Book Archive